Re: nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT.

Overview

authors

Mathieu, Romain

Shariat, Shahrokh

publication date

September 1, 2015

published in

European urology Journal

Research

keywords

Androgen Antagonists
Prostatic Neoplasms, Castration-Resistant
Testosterone

Identity

Scopus Document Identifier

84940532747

Digital Object Identifier (DOI)

10.1016/j.eururo.2015.05.027

PubMed ID

26282354

Additional Document Info

volume

68

issue

3